Eric Wachter
Provectus Pharmaceuticals has shuffled its board in a bid to trade on the national stock market.
President of investment firm GoStar Jan Koe has been placed on the board, and Provectis’ Eric Wachter will leave.
Wachter will now take on the newly created position of chief technology officer for the firm.
The move means the company now meets NASDAQ corporate governance requirements, which calls for a majority of independent directors.
Craig Dees, CEO, said: “As a business leader, Jan Koe has experience serving on the board of a public company, and will be an important asset to us as we prepare Provectus for a potential move to listing on a national stock market.”